Home | Life Sciences Intellectual Property Review
WEB6 days ago · In its first year, uptake of cases at the Unified Patent Court has surpassed most expectations. Darren Smyth of EIP delves into the facts and figures behind the headlines, with some surprising results. 26 September 2024 Cameron Marshall, partner at Carpmaels, offers a behind-the-scenes snapshot of working a UPC case with tight deadlines and an ...
Latest News & Features | Life Sciences Intellectual Property Review
WEBPreventative IP for preventative pharma healthcare. The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert. 24 September 2024. Americas.
How to navigate patent term adjustment in China
WEB12 hours ago · Same-date filing strategy. Rule 78.4 further excludes the eligibility of invention applications that take advantage of the utility model + invention ‘same day filing strategy’ (see our previous article).This refers to the situation where the applicant chooses to give up an earlier granted utility model patent to obtain the rights of the counterpart invention patent that was filed on the ...
Americas | Life Sciences Intellectual Property Review
WEB13 February 2024 US Patent and Trademark Office publishes ‘clear’ guidance mandating AI-related patents to have ‘significant’ human involvement | Cites one hypothetical example relating to the development of a compound for treating cancer | Kathi Vidal: ‘patent system was developed to incentivise and protect human ingenuity’.
Unified Patent Court | Life Sciences Intellectual Property Review
WEB12 December 2023 Hearing is latest in dispute between the biotech research firms | Multi-jurisdictional case concerns patents relating to the in-situ detection of analytes. 28 November 2023 UPC judge, EPO director and Regeneron counsel shed light on the court’s dynamics at London event | Life sciences sector emerging as a major player in the ...
Biotechnology | Life Sciences Intellectual Property Review
WEB17 September 2024 Court finds United Therapeutics breached settlement agreement by restricting distribution of cartridges | Sandoz alleged rival hampered launch of generic medication for pulmonary arterial hypertension
Generics | Life Sciences Intellectual Property Review
WEBThe pharma company’s arguments focusing on ‘inventive step’ failed to convince a London court that the Israeli generic drug maker had infringed, explains Azadeh Vahdat of EIP. 28 March 2024 Judge disagrees that barrier against generic drug makers should be longer | Pharma company argues that ‘window should be shut’ on copycat versions ...
CRISPR | Life Sciences Intellectual Property Review
WEB9 November 2020 The European Patent Office has released the long-awaited reasoning for its decision to uphold the revocation of a Broad Institute CRISPR/Cas9 patent. In January this year, the EPO’s Board of Appeal concluded that the Broad’s patent, EP2,771,468, lacked novelty due to an invalid claim to priority.
Magazine Archive | Life Sciences Intellectual Property Review
WEBMagazine Archive. Click the thumbnails below to view the Life Sciences IP Review magazines. LSIPR Spring/Summer 2022. Spring is here and the UK government is marking it by airing its Genetic Technology (Precision Breeding) Bill, promising to breathe new life into an area apparently suffocated by EU red tape. LSIPR new recruit Sarah Speight asks ...
The future of precision medicine part 1: challenges and …
WEBJun 13, 2018 · The promise of precision medicine has been extolled by researchers and clinicians for some time, but as sequencing costs continue to fall, sophistication of data analysis and patient stratification increases and data science and artificial intelligence (AI) begin to partner with the life sciences industry in earnest, that promise now seems closer than ever to realisation.